SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "L773:0007 0963 "

Sökning: L773:0007 0963

Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  • Alam, M., et al. (författare)
  • An osteopontin-derived peptide inhibits human hair growth at least in part by decreasing fibroblast growth factor-7 production in outer root sheath keratinocytes
  • ????
  • Ingår i: British Journal of Dermatology. - Wiley-Blackwell. - 0007-0963.
  • Tidskriftsartikel (refereegranskat)abstract
    • Background: Given that unwanted hair growth (hirsutism, hypertrichosis) can cause major psychological distress, new pharmacological treatment strategies with safe and effective hair growth inhibitors that do not destroy the hair follicle (HF) and its stem cells need to be developed. Objectives: To establish if osteopontin-derived fragments may modulate human hair growth given that human HFs express the multifunctional, immunomodulatory glycoprotein, osteopontin. Methods: Our hypothesis was tested ex vivo and in vivo by using a newly generated, toxicologically well-characterized, modified osteopontin-derived peptide (FOL-005), which binds to the HF. Results: In organ-cultured human HFs and scalp skin, and in human scalp skin xenotransplants onto SCID mice, FOL-005 treatment (60 nmol L−1 to 3 μmol L−1) significantly promoted premature catagen development without reducing the number of keratin 15-positive HF stem cells or showing signs of drug toxicity. Genome-wide DNA microarray, quantitative reverse-transcriptase polymerase chain reaction and immunohistochemistry revealed decreased expression of the hair growth promoter, fibroblast growth factor-7 (FGF7) by FOL-005, while cotreatment of HFs with recombinant FGF7 partially abrogated FOL-005-induced catagen promotion. Conclusions: With caveats in mind, our study identifies this osteopontin-derived peptide as an effective, novel inhibitory principle for human hair growth ex vivo and in vivo, which deserves systematic clinical testing in hirsutism and hypertrichosis. What's already known about this topic?. The treatment of unwanted hair growth (hypertrichosis, hirsutism) lacks pharmacological intervention, with only few and often unsatisfactory treatments available. Osteopontin is prominently expressed in human HFs and has been reported to be elevated during catagen in the murine hair cycle. What does this study add?. We tested the effects on hair growth of a novel, osteopontin-derived fragment (FOL-005) ex vivo and in vivo. In human hair follicles, high-dose FOL-005 significantly reduces hair growth both ex vivo and in vivo. What is the translational message?. High-dose FOL-005 may provide a new therapeutic opportunity as a treatment for unwanted hair growth.
  •  
2.
  • Alexeyev, Oleg A. (författare)
  • Psoriasis, gut and microbiome
  • 2019
  • Ingår i: British Journal of Dermatology. - John Wiley & Sons. - 0007-0963 .- 1365-2133. ; 181:6, s. 1126-1126
  • Tidskriftsartikel (övrigt vetenskapligt)
  •  
3.
  •  
4.
  • Amatya, B, et al. (författare)
  • Expression of tachykinins and their receptors in plaque psoriasis with pruritus
  • 2011
  • Ingår i: BRITISH JOURNAL OF DERMATOLOGY. - Blackwell Publishing Ltd. - 0007-0963. ; 164:5, s. 1023-1029
  • Tidskriftsartikel (refereegranskat)abstract
    • <p>Pandgt;Background Cutaneous melanoma is rapidly increasing in incidence worldwide and approximately 5% of melanomas are hereditary. Deletions in chromosome 1p36 have been detected in melanoma but no candidate melanoma tumour suppressor gene has yet been found in this area. Recently, strong evidence has been reported that CHD5 is a tumour suppressor gene in this region. Objectives To investigate CHD5 involvement in familial melanoma. Methods Peripheral blood DNA from 47 melanoma families who do not carry mutations in any of the three currently recognized melanoma genes, 398 patients with sporadic melanoma and 398 geographically matched nonmelanoma-bearing controls were studied. Linkage investigation, single nucleotide polymorphism (SNP) genotyping and mutation screening studies were carried out on the CHD5 locus. Results The CHD5 gene was not excluded by linkage analysis in any of the families. On SNP genotyping, the CHD5 rs7513548 SNP was found to be significantly associated with sporadic melanoma (odds ratio 1 center dot 53, 95% confidence interval 1 center dot 13-2 center dot 06). The AG genotype was found in 208 cases and 169 controls (cf. 141 and 175 cases and controls, respectively, for the AA genotype). On CHD5 mutation screening, a total of 50 single-base substitutions were detected. Of these, 39 were intronic and 11 were exonic. While 32 were previously recognized variants, 18 were newly identified. Three, in exons 4, 31 and 32, led to nonsynonymous substitutions. A p.Met1576Ile substitution was identified in a mother and daughter, both with invasive cutaneous melanoma. Conclusions This study appears to be the first report of CHD5 variants in familial cutaneous melanoma. Such CHD5 variants could block or alter the ability of CHD5 to regulate the cell cycle pathway and to effect cellular control. As only one of the 47 families studied has this variant, it appears to be a rare event and further screening of melanoma families is required to confirm whether or not CHD5 is involved in melanoma pathogenesis.</p>
  •  
5.
  • Anderson, K S, et al. (författare)
  • Detection of psoriasin/S100A7 in the sera of patients with psoriasis
  • 2009
  • Ingår i: British Journal of Dermatology. - 0007-0963 .- 1365-2133. ; 160:2, s. 325-332
  • Tidskriftsartikel (refereegranskat)abstract
    • <p>BACKGROUND: Psoriasis is a disease of dysregulated inflammation and epithelial hyperproliferation in the skin, involving both the innate and adaptive immune system. Psoriatic keratinocytes express high levels of psoriasin (S100A7), a small calcium-binding protein. OBJECTIVES: To determine if patients with active psoriasis have elevated serum levels of psoriasin and psoriasin-specific autoantibodies. METHODS: Blood was collected from 14 patients with psoriasis vulgaris at the start of narrowband ultraviolet (UV) B therapy and from 11 of these patients every 2 weeks during the course of the UVB treatment. Patient and control sera were tested for psoriasin antigen levels by sandwich enzyme-linked immunosorbent assay, and for psoriasin autoantibody titres using recombinant purified psoriasin and overlapping peptides. RESULTS: We confirmed strong and specific expression of psoriasin in psoriatic epidermis by immunohistochemistry. Systemic psoriasin antigen levels tended to be lower in patients (mean 213 ng mL(-1)) than in controls (mean 331 ng mL(-1), P = 0.308) and decreased with increasing disease severity. Psoriasin-specific autoantibodies were detected in a subset of patients with psoriasis and healthy normal donors (mean 0.347 vs. 0.255 units, P = 0.246). The epitopes recognized by the autoantibodies were mapped to an external loop domain of the molecule but did not show corresponding T-cell immunogenicity. CONCLUSIONS: Although psoriasin is overexpressed in psoriatic skin lesions, systemic levels of psoriasin tended to be lower with increasing disease severity, which may be due to the presence of psoriasin-specific autoantibodies. Neither psoriasin nor psoriasin-specific autoantibodies appear to be promising serum biomarkers for clinical psoriasis.</p>
  •  
6.
  • Anderson, K S, et al. (författare)
  • Elevation of serum epidermal growth factor and interleukin 1 receptor antagonist in active psoriasis vulgaris
  • 2010
  • Ingår i: BRITISH JOURNAL OF DERMATOLOGY. - Blackwell Publishing Ltd. - 0007-0963. ; 163:5, s. 1085-1089
  • Tidskriftsartikel (refereegranskat)abstract
    • <p>Background Psoriatic plaques present a complex expression profile, including high levels of cytokines, chemokines and growth factors. Circulating cytokines have been suggested to reflect the activation status of the inflammatory process. Objectives To analyse 20 cytokines, chemokines and growth factors in 14 patients with psoriasis vulgaris at the start and during the course of ultraviolet B treatment. Methods A multiplex cytokine assay was used. Results We identified increased serum levels of epidermal growth factor (EGF) (mean 323 vs. 36 6 pg mL(-1), P = 0 0001), interleukin (IL)-1 receptor antagonist (mean 39 1 vs. 14 6 pg mL(-1), P = 0 02) and tumour necrosis factor-alpha (mean 7 5 vs. 4 5 pg mL(-1), P = 0 04) at baseline in patients with psoriasis compared with matched controls. None of these cytokines was correlated to the severity of the disease (Psoriasis Area and Severity Index) or decreased with phototherapy, suggesting that sources other than lesional skin contribute to the production of these cytokines. Using cluster analysis, we observed coordinate upregulation of EGF, IL-6, macrophage inflammatory protein-1 beta and vascular endothelial growth factor. Conclusions The sustained high expression of inflammatory circulating cytokines is a potential mechanism linking psoriasis with its extracutaneous comorbidities.</p>
  •  
7.
  •  
8.
  •  
9.
  • Asplund, A., et al. (författare)
  • Expression profiling of microdissected cell populations selected from basal cells in normal epidermis and basal cell carcinoma
  • 2008
  • Ingår i: British Journal of Dermatology. - 0007-0963 .- 1365-2133. ; 158:3, s. 527-538
  • Tidskriftsartikel (refereegranskat)abstract
    • <p>Background Basal cell carcinomas (BCCs) are prevalent tumours with uniform histology that develop without any known precursor lesion. Alterations in the sonic hedgehog-patched1 signalling pathway are accepted as necessary events for tumorigenesis, and mutations in the patched1 gene are frequently present in tumours. Objectives To analyse transcript profiles in BCC. Methods We used laser-assisted microdissection to isolate and collect cell populations defined under the microscope. Peripheral cells from nests of BCC were selected to represent tumour cells, and normal keratinocytes from epidermis basal layer were used as control. Extracted RNA was amplified and hybridized on to a cDNA microarray. Results Our results show that BCC cells express a transcript signature that is significantly different from that of normal keratinocytes, and over 350 genes with various functions were identified as differentially expressed. The compiled data suggest an upregulation of the Wnt signalling pathway as a major event in BCC cells. Furthermore, tumour cells appear to have an increased sensitivity to oxygen radicals and dysregulated genes involved in antigen presentation. Results were validated at both the transcriptional level using real-time polymerase chain reaction and at the protein level using immunohistochemistry. Conclusions We show that microdissection in combination with robust strategies for RNA extraction, amplification and cDNA microarray analysis allow for reliable transcript profiling and that antibody-based proteomics provides an advantageous strategy for the analysis of corresponding differentially expressed proteins. We found that expression patterns were significantly altered in BCC cells compared with basal keratinocytes and that the Wnt signalling pathway was upregulated in tumour cells.</p>
  •  
10.
  • Asplund, Anna, et al. (författare)
  • Expression profiling of microdissected cell populations selected from basal cells in normal epidermis and basal cell carcinoma
  • 2008
  • Ingår i: British Journal of Dermatology. - 0007-0963 .- 1365-2133. ; 158:3, s. 527-38
  • Tidskriftsartikel (refereegranskat)abstract
    • <p>BACKGROUND: Basal cell carcinomas (BCCs) are prevalent tumours with uniform histology that develop without any known precursor lesion. Alterations in the sonic hedgehog-patched1 signalling pathway are accepted as necessary events for tumorigenesis, and mutations in the patched1 gene are frequently present in tumours. OBJECTIVES: To analyse transcript profiles in BCC. METHODS: We used laser-assisted microdissection to isolate and collect cell populations defined under the microscope. Peripheral cells from nests of BCC were selected to represent tumour cells, and normal keratinocytes from epidermis basal layer were used as control. Extracted RNA was amplified and hybridized on to a cDNA microarray. Results Our results show that BCC cells express a transcript signature that is significantly different from that of normal keratinocytes, and over 350 genes with various functions were identified as differentially expressed. The compiled data suggest an upregulation of the Wnt signalling pathway as a major event in BCC cells. Furthermore, tumour cells appear to have an increased sensitivity to oxygen radicals and dysregulated genes involved in antigen presentation. RESULTS: were validated at both the transcriptional level using real-time polymerase chain reaction and at the protein level using immunohistochemistry. CONCLUSIONS: We show that microdissection in combination with robust strategies for RNA extraction, amplification and cDNA microarray analysis allow for reliable transcript profiling and that antibody-based proteomics provides an advantageous strategy for the analysis of corresponding differentially expressed proteins. We found that expression patterns were significantly altered in BCC cells compared with basal keratinocytes and that the Wnt signalling pathway was upregulated in tumour cells.</p>
  •  
Skapa referenser, mejla, bekava och länka
Åtkomst
fritt online (19)
Typ av publikation
tidskriftsartikel (228)
konferensbidrag (12)
forskningsöversikt (2)
Typ av innehåll
refereegranskat (212)
övrigt vetenskapligt (41)
Författare/redaktör
Svensson, A (15)
Emtestam, L, (15)
Vahlquist, Anders, (13)
Hagforsen, Eva, (13)
Michaelsson, Gerd, (11)
Lindholm, C (8)
visa fler...
Törmä, Hans, (8)
von Kobyletzki, Laur ... (8)
Hansson, J, (7)
Schmitt, J. (7)
Lindelof, B, (7)
Fischer, J., (7)
Meding, B (7)
Lindberg, M (7)
Ingvar, C (7)
Maroti, M (7)
Lapins, J., (7)
Williams, H. C., (7)
Scheynius, A, (6)
Nordlind, K, (6)
Traupe, H (6)
Langan, S. M. (6)
Kraaz, W, (6)
Spuls, P. I., (6)
Gerbens, L. A.A., (6)
von Kobyletzki, L. B ... (6)
Stierner, U (6)
Schmitt-Egenolf, Mar ... (6)
Ganemo, A (6)
Chalmers, J. R., (6)
Thomas, K. S. (6)
Bourrat, E., (6)
Ponten, F (5)
Saarialho-Kere, U, (5)
Meding, Birgitta (5)
Enerbäck, Charlotta, (5)
Mansson-Brahme, E, (5)
Naredi, P (5)
Simpson, E (5)
SIGURGEIRSSON, B (5)
Flohr, C (5)
Ros, AM (5)
Bygum, A. (5)
Barbarot, S., (5)
Abuabara, K., (5)
Aoki, V., (5)
Burton, T., (5)
Smirnova, J., (5)
Diociaiuti, A. (5)
El Hachem, M. (5)
visa färre...
Lärosäte
Karolinska Institutet (72)
Uppsala universitet (50)
Linköpings universitet (27)
Umeå universitet (26)
Lunds universitet (21)
Göteborgs universitet (20)
visa fler...
Örebro universitet (12)
Karlstads universitet (7)
Kungliga Tekniska Högskolan (4)
Stockholms universitet (4)
Högskolan i Jönköping (1)
swepub_uni:mau_t (1)
Högskolan i Halmstad (1)
Blekinge Tekniska Högskola (1)
visa färre...
Språk
Engelska (236)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (162)
Naturvetenskap (2)
Teknik (2)

År

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy